Proteon reports positive results from PRT-201 Phase 2 trial in chronic kidney disease patients
The double-blind, placebo-controlled study randomized 151 patients with either one of two doses of PRT-201, or placebo to evaluate the safety and efficacy of PRT-201 delivery subsequent to